A former Arkansas House minority leader announced a plan to put a marijuana legalization initiative on the state’s 2022 ballot. Meanwhile, activists are already collecting signatures for a separate legal cannabis proposal.
The Michigan House Regulatory Reform Committee approved bills to enact home cultivation restrictions on medical cannabis caregivers. Patient advocates argue it’s a “power move” by “big money investors.”
A new poll found that 83 percent of Washington, D.C likely voters support decriminalizing drugs in the nation’s capital. Activists with DecrimPovertyDC just launched a campaign to press the District Council to enact the broadly supported reform.
A poll shows that marijuana legalization is more popular with Maryland residents than President Joe Biden or the state’s two Democratic U.S. senators are.
U.S. Virgin Islands Gov. Albert Bryan Jr. (D) and lawmakers from the territory are visiting Colorado this week for a summit about cannabis issues as they work to pass a legalization bill.
New Oklahoma medical cannabis laws on pre-rolled joints, sampling and inspections take effect on Monday.
A Minnesota representative spoke about risking his gun rights by using medical cannabis to treat multiple sclerosis.
A Pennsylvania senator tweeted, “It is time for Pennsylvania to join the growing movement toward cannabis legalization. Pennsylvanians should not have to travel and give their tax dollars to neighboring states just to consume something that already has majority support in Pennsylvania.”
Virginia regulators issued rules removing requirements for reporting misdemeanor marijuana convictions of applicants for various professional licenses.
Montana’s top marijuana regulator said officials plan to release additional proposed rules this week.
PayPal Holdings Inc. is being sued for allegedly improperly locking the accounts of CBD business Friends NYC.
A review concluded that “CBD has been reported to have several therapeutic properties including anxiolytic, antidepressant, anti-inflammatory, anti-emetic, analgesic, as well as reduction of cue-induced craving for opioids, all of which are highly relevant to opioid withdrawal syndrome.”
source
